Molecular processes for targeted dog cancer therapy investigated
Dogs get cancer, just like humans. Scientists are now exploring the molecular basis of cancer progression in canine cell lines. Modern cancer therapy has been revolutionized with the introduction of new drugs, so-called ‘targeted drugs’, but the basis for the application of these new agents in cancer therapy is a deep understanding of the molecular mechanisms of the disease, even with pets. Now a research team has investigated the activation of genetic regulatory mechanisms in canine cells and found both matches as well as differences compared to humans.
0 Comments
Recommended Comments
There are no comments to display.